Institutional Ownership
Urogen Pharma Ltd
CUSIP M96088105COMURGNQ1 2026
13D / 13G Filings
51
Schedule 13D/13G on record
Beneficial Filers
24
Distinct reporting persons
Largest Stake
14.1%
Max % of class reported
Institutional Holders
165
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
51 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | The Toronto-Dominion Bank | 13G/A | 4.9% | 2.30M | SEC |
| 2 | Nov 14, 2025 | Cowen Financial Products LLC | 13G/A | — | — | SEC |
| 3 | Nov 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 9.0% | 9.23B | SEC |
| 4 | Nov 14, 2025 | The Toronto-Dominion Bank | 13G | 6.9% | 3.19M | SEC |
| 5 | Aug 14, 2025 | Ra Capital Management, L.P. | 13G/A | — | 913.30M | SEC |
| 6 | Aug 12, 2025 | Paradigm Biocapital Advisors LP | 13G | 5.0% | 925.20M | SEC |
| 7 | Aug 6, 2025 | Morgan Stanley | 13G | 5.4% | 2.49M | SEC |
| 8 | Aug 5, 2025 | Soleus Capital Master Fund, L.P. | 13G/A | 4.7% | 2.19M | SEC |
| 9 | Jul 29, 2025 | Cowen Financial Products LLC | 13G/A | 6.9% | 3.19M | SEC |
| 10 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 5.0% | 2.28M | SEC |
41 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Urogen Pharma Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rtw Investments, LP | 4.54M | $81.70M |
| 2 | Blackrock, Inc. | 2.85M | $51.16M |
| 3 | Toronto Dominion Bank | 2.62M | $47.05M |
| 4 | Morgan Stanley | 2.56M | $46.03M |
| 5 | Kynam Capital Management, LP | 2.25M | $40.41M |
| 6 | Jefferies Financial Group Inc. | 2.20M | $39.55M |
| 7 | Paradigm Biocapital Advisors LP | 1.70M | $30.64M |
| 8 | Acorn Capital Advisors, LLC | 1.67M | $30.09M |
| 9 | American Century Companies Inc | 1.64M | $29.44M |
| 10 | Silverarc Capital Management, LLC | 1.50M | $27.02M |